Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and 13C stable isotope labeling
2014
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection
2006
Engineering precision nanoparticles for drug delivery
2020 Standout
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
2009
Natural products: An evolving role in future drug discovery
2011 Standout
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Cytochrome P450 reaction-phenotyping: an industrial perspective
2007
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs
2008
Caspofungin
2003
Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection
2008
Hallmarks of aging: An expanding universe
2023 Standout
Metabolism, Excretion, and Pharmacokinetics of ((3,3-Difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, a Dipeptidyl Peptidase Inhibitor, in Rat, Dog and Human
2012
Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists
2011
Human Liver Expression of CYP2C8: Gender, Age, and Genotype Effects
2010
Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol‐3‐sulfate
2003
Network pharmacology: the next paradigm in drug discovery
2008 Standout
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir
2009
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review
2006
Newer Systemic Antifungal Agents
2004
High and low activity rats: Elevated intrinsic physical activity drives resistance to diet‐induced obesity in non‐bred rats
2013
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
2008
Emerging echinocandins for treatment of invasive fungal infections
2006
Caspofungin: first approved agent in a new class of antifungals
2003
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
The use of spirocyclic scaffolds in drug discovery
2014 Standout
Orexin receptors as therapeutic drug targets
2012
Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
2010
Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses
2010
An integrated method for metabolite detection and identification using a linear ion trap/Orbitrap mass spectrometer and multiple data processing techniques: application to indinavir metabolite detection
2007
Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review
2017 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Caspofungin
2005
Caspofungin: the first representative of a new antifungal class
2003
Safety and tolerability of caspofungin acetate in the treatment of fungal infections
2002
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Caspofungin: the first in a new class of antifungal agents
2003
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Selective determination of COXIBs in environmental water samples by mixed-mode solid phase extraction and liquid chromatography quadrupole time-of-flight mass spectrometry
2015
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
2013
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet
2017 Standout
Microengineered Liver Tissues for Drug Testing
2015
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin
2005
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Antifungal agents: mechanisms of action
2003 Standout
Global metabolic profiling procedures for urine using UPLC–MS
2010 Standout
Isotopic Signature Transfer and Mass Pattern Prediction (IsoStamp): An Enabling Technique for Chemically-Directed Proteomics
2011 StandoutNobel
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model
2017
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis
2014
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
2017
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources
2014 Standout
Cytochrome P450 2C8 Pharmacogenetics: A Review of Clinical Studies
2009
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Use of Robust Classification Techniques for the Prediction of Human Cytochrome P450 2D6 Inhibition
2003
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
Caspofungin
2003
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
1997
Integration of Knowledge-Based Metabolic Predictions with Liquid Chromatography Data-Dependent Tandem Mass Spectrometry for Drug Metabolism Studies: Application to Studies on the Biotransformation of Indinavir
2003
Oxadiazoles in Medicinal Chemistry
2011 Standout
Safety and Toxicology of Magnolol and Honokiol
2018 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Echinocandins - an update
2002
Pharmacology of Systemic Antifungal Agents
2006
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Biospectra Analysis: Model Proteome Characterizations for Linking Molecular Structure and Biological Response
2005
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Enhancing the functional maturity of induced pluripotent stem cell–derived human hepatocytes by controlled presentation of cell–cell interactions in vitro
2014
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
2009
Burn Wound Infections
2006 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug Discovery
2000
A New Portal to SuFEx Click Chemistry: A Stable Fluorosulfuryl Imidazolium Salt Emerging as an “F−SO2+” Donor of Unprecedented Reactivity, Selectivity, and Scope
2017 StandoutNobel
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
2020
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
2019
METLIN
2005 Standout
Works of Donghui Cui being referenced
Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography/ tandem mass spectrometry
1998
Cytochrome P450 3A-Dependent Metabolism of a Potent and Selective γ-Aminobutyric AcidAα2/3 Receptor Agonist in Vitro: Involvement of Cytochrome P450 3A5 Displaying Biphasic Kinetics
2007
METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
2003
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions
2000
Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol
2007
Biotransformation of [14C]Dasatinib: In Vitro Studies in Rat, Monkey, and Human and Disposition after Administration to Rats and Monkeys
2008
Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro
2008
Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy Male Volunteers
2003
Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
2011
Identification of the Human Enzymes Involved in the Oxidative Metabolism of Dasatinib: An Effective Approach for Determining Metabolite Formation Kinetics
2008
Metabolism and Disposition of Dasatinib after Oral Administration to Humans
2008
Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
2013
Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme
2007
Identification of drug metabolites in biological matrices by intelligent automated liquid chromatography/ tandem mass spectrometry
1998
Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
1998
Identification of in vitro metabolites of indinavir by “intelligent automated LC-MS/MS” (INTAMS) utilizing triple quadrupole tandem mass spectrometry
1999
SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL
2004
Metabolic chiral inversion of stiripentol in the rat. I. Mechanistic studies.
1994
Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
1997
Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
2011
Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine
2000